Furthermore, we detected a higher consumption (reduction) of EndoCAb IgG when compared to EndoCAb IgM, as suggested by a decreased IgG/IgM titres ratio in patients with early AF when compared to the controls, which suggests a rather chronic process (Figure 2D). This evidence concerns the gene CD40LG and atrial fibrillation.